Author Archives: donttradeourlivesaway

Speak up for affordable medicine

Iol news, Nobember 19, 2015. US and European pharmaceutical industries see South Africa as “ground zero” for keeping their large profit margins, say Julia Hill and Catherine Tomlinson. 

Posted in BRICS, Drug Pricing, Fix the patent law, South Africa's Patent Act | Leave a comment

WHO proposes to join Global Fund’s IP enforcement initiative

Third World Network, November 19, 2015. By KM Gopakumar. Geneva – The World Health Organization has proposed to join the intellectual property enforcement initiative of the Global Fund to Fight AIDS, Tuberculosis and Malaria (Global Fund).

Posted in Counterfeit, Global Fund, WHO | Leave a comment

The Daraprim Case: How a Drug’s Price Rose by 75,000 %

The recent price hike of Daraprim, a 62 year old medicine used against toxoplasmosis, created a massive public outcry against Turing Pharmaceuticals, who had just acquired the drug, and its CEO Martin Shkreli, making him “the most hated man in America”. How is … Continue reading

Posted in Drug Pricing, Drug regulation | Leave a comment

Most WTO members seek to continue Doha round talks at Nairobi meet

Livemint, November 23, 2015. Geneva – Many members of the World Trade Organization (WTO) have called for reaffirming the commitment to continue negotiations on all outstanding issues of the Doha Development Agenda (DDA) at the Nairobi Ministerial Declaration, a panel of … Continue reading

Posted in TRIPS, WTO | Leave a comment

US, Switzerland back out of disputed norm in patent law

Livemint, November 23, 2015. Geneva –  The US and Switzerland have agreed not to introduce a controversial norm in the global patent law regime for pharmaceutical products for another two years until end-2017 at the World Trade Organization (WTO), according to … Continue reading

Posted in Non-violation complaints, TRIPS, WTO | Leave a comment

Strength In Unity: Mercosur Countries Join To Negotiate Lower Prices For Hepatitis C and HIV Drugs

Source: IP Watch 19 Nov 2015 South American countries are negotiating with pharmaceutical companies to obtain common cheaper prices for high-cost medicines. The first target of initial negotiations delivered lower prices for hepatitis C and HIV. Further negotiations are expected … Continue reading

Posted in Drug Pricing, Hepatitis C, Patents | Leave a comment

Who Owns the Patent on Nutmeg?

The New Yorker; October 26, 2015. The next time your neighborhood barista offers you a character sketch of the beans that went into making your Chemex pour-over, try asking him about biopiracy, the appropriation of indigenous knowledge of nature by corporations … Continue reading

Posted in Uncategorized | Leave a comment